news
Quotient Clinical appoints Azhar Kalim as Chief Commercial Officer
30 May 2017 | By Quotient Clinical
Appointment supports Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions...
List view / Grid view
Quotient Clinical
whitepaper
Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs
In this whitepaper, Quotient Clinical discuss poorly soluble drugs and how they have developed an innovative approach to identify and overcome these solubility challenges...
article
Spray drying – various challenges, one solution?
Spray drying is a proven, flexible and scalable process used within the pharmaceutical industry to address a wide range of formulation and drug delivery challenges. Its versatility has been proven through applications to both small chemical and biopharmaceutical drugs for product delivery via multiple routes of administration.
news
Quotient Clinical hosts formulation development and drug delivery seminar series
15 June 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, is holding a series of formulation development and drug delivery seminars this June and July...
news
Quotient Clinical and Upperton announce a spray drying partnership to deliver integrated formulation development and GMP manufacturing programs for poorly soluble drugs
4 May 2016 | By Quotient Clinical
Quotient Clinical and Upperton have announced a partnership to address drug delivery challenges...
news
Quotient Clinical incorporates Japanese bridging into a Translational Pharmaceutics® program
15 March 2016 | By Quotient Clinical
Quotient Clinical has announced the completion of its first clinical program involving Japanese healthy volunteers...
news
Quotient Clinical showcases Enabled-First-in-Human® programs at ASCPT 2016
1 March 2016 | By Quotient Clinical
Quotient Clinical will be showcasing its Enabled-First-in-Human® programs at the upcoming ASCPT Meeting 2016...
news
Quotient Clinical celebrates its 100th RapidFACT® program
11 February 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues...
news
Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate
16 December 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited...
news
Quotient Clinical showcases Translational Pharmaceutics and RapidFACT at AAPS 2015
13 October 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, will be highlighting the benefits of its unique, integrated approach to formulation development, real-time adaptive manufacturing and clinical testing on booth 1662...
news
Quotient Clinical CEO Mark Egerton a winner at UK EY Entrepreneur of the Year 2015 awards
13 October 2015 | By Quotient Clinical
Quotient Clinical has announced that CEO Mark Egerton has received an EY Entrepreneur of the Year® 2015 UK Award...
news
Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham
12 August 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced that Dr Peter Scholes, its Chief Scientific Officer, has been awarded an honorary professorship in the School of Pharmacy at the University of Nottingham...
news
Quotient Clinical announces expansion of pharmaceutical sciences capacity
14 July 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced a significant expansion of its pharmaceutical sciences capabilities...
news
Quotient Clinical acquires second GMP manufacturing facility
14 July 2015 | By Victoria White
Quotient Clinical is to expand its pharmaceutical sciences capabilities. This includes the acquisition of a second GMP manufacturing facility...
news
Quotient Clinical delivers breakthrough first-in-human program for Corcept Therapeutics
10 June 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, has announced the successful completion of an Enabled-First-in-Human® (Enabled-FIH) program for US biotech company Corcept Therapeutics Incorporated...
